5.4 ± 22.0 events/hour; p < .05), but failed to reach significance at the low and high doses.
← all excerpts
A randomized dose finding study of combination dronabinol and acetazolamide for the treatment of obstructive sleep apnea.
1
—
—
5.4 ± 22.0 events/hour; p < .05), but failed to reach significance at the low and high doses.